Fosun Pharma reports 5.71% net profit growth in first three quarters
Fosun Pharma’s net profit rose 5.71% in the first three quarters.
Related stories
Freddie Mac net income rises 17% year over year in Q3 2026
M impact | EARNINGS | Oct 29, 2026, 12:08 PM UTC
Establishment Labs Expects 2026 Revenue Over $274M
The company expects 2026 revenue to exceed $274 million, versus a FactSet estimate of $270.2 million.
M impact | EARNINGS | Oct 29, 2026, 12:06 PM UTC
Insperity Q3 Adjusted EPS Is USD 0.22 vs. IBES Estimate of USD 0.21
Insperity reported Q3 gross profit of USD 207 million.
M impact | EARNINGS | Oct 29, 2026, 12:06 PM UTC
Alphabet Shares Fall After Third-Quarter Earnings Miss
Alphabet shares fell in Wednesday postmarket trading after third-quarter earnings missed Wall Street expectations, despite a strong performance from Google Cloud.
M impact | EARNINGS | Oct 29, 2026, 12:06 PM UTC
Chipotle Shares Rise 7.55% in Premarket After Traffic Growth
Chipotle reported third-quarter adjusted EPS of $0.27, below the $0.29 analyst consensus, and revenue of $3.29 billion, in line with estimates. Revenue rose 9.6%, driven mainly by
M impact | EARNINGS | Oct 29, 2026, 12:06 PM UTC
Boliden Sees Full-Year Aitik Copper Grade at 0.16%, Milled Volume at 42 Mtonnes
Boliden’s earlier view was 0.18% copper grade and 41 Mtonnes of milled volume.
M impact | EARNINGS | Oct 29, 2026, 12:06 PM UTC